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Abstract
An organism stems from assemblies of a variety of cells and proteins. This complex system serves as a unit, and it exhibits 
highly sophisticated functions in response to exogenous stimuli that change over time. The complete sequencing of the entire 
human genome has allowed researchers to address the enigmas of life and disease at the gene- or molecular-based level. The 
consequence of such studies is the rapid accumulation of a multitude of data at multiple levels, ranging from molecules to 
the whole body, that has necessitated the development of entirely new concepts, tools, and methodologies to analyze and 
integrate these data. This necessity has given birth to systems biology, an advanced theoretical and practical research frame-
work that has totally changed the directions of not only basic life science but also medicine. During the symposium of the 
95th Annual Meeting of The Physiological Society of Japan 2018, five researchers reported on their respective studies on 
systems biology. The topics included reactions of drugs, ion-transport architecture in an epithelial system, multi-omics in 
renal disease, cardiac electrophysiological systems, and a software platform for computer simulation. In this review article 
these authors have summarized recent achievements in the field and discuss next-generation studies on health and disease.
Keywords Systems biology · Physiological experiments · Omics study · Computer simulation · Software platform
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Introduction
The approach of scientists toward the life sciences was dra-
matically revolutionized by the advent of molecular biol-
ogy several decades ago and its associated power of ulti-
mate reductionism. This movement was further strongly 
boosted by the complete sequencing of entire human 
genome, which is now enabling the enigma of life and 
disease to be deciphered from the point of view of gene- 
or molecule-based functionalities. As a consequence, in 
concert with methodological innovations, entirely new 
and diverse bodies of knowledge are accumulating at a 
rapid and unprecedented pace, culminating in deposition 
of massive amounts of data, such as multiple ‘omics’ and 
other high-throughput data, in intractably huge databases. 
However, this flood of information simultaneously neces-
sitates new optimal concepts/logics and tools for analyz-
ing/integrating the data accumulated at multiple functional 
levels, ranging from molecules to the whole body. The 
field of systems biology emerged from this serious need 
for new theoretical/practical frameworks for analyzing and 
integrating these enormous chunks of information [1–3]. 
Subsequently, these frameworks have extensively driven 
many system-level analyses and integrations of existing 
data, thereby totally changing the directions of medicine, 
as indicated by the terms ‘precision medicine’ or ‘person-
alized medicine.’ More recently, the strategic initiatives in 
most developed countries are aimed at ‘preemptive medi-
cine’ and ‘regenerative medicine,’ in which resilience, 
repair, and replacement are key concepts. Importantly, 
the essence of resilience lies in the reversible continuum 
between health and disease, and thus one of the present 
aims is to understand how resilience to disease develops 
and breaks down and to discover the way to prevents this 
breakdown by appropriate medical interventions and/or 
regimens aimed at health promotion. This difficult mis-
sion will be accomplished not only by discovering the new 
system-level logics and principles governing normal bio-
logical function across all hierarchical levels of the body 
(from molecules through to organ functions to behaviors/
environmental adaptations), but by re-integrating these in 
such a way as to reconstruct a realistic multi-scale, multi-
physics system that can reproduce the continuum of health 
and disease [4, 5].
This symposium was held during the 95th Annual 
Meeting of The Physiological Society of Japan (Taka-
matsu, Japan, on March 28, 2018). It was organized in 
an eager attempt to explore the newest landscape of mod-
ern medicine based on system-level approaches through 
the presentation of the most recent studies conducted 
by five front-runners in their respective field of systems 
biology [6]. The topics of these presentations include: 
(1) ‘System-based understanding of adverse reactions of 
molecularly targeted drugs’ by Yoshiaki Kariya, Masashi 
Honma, and Hiroshi Suzuki; (2) ‘Multi-omics approaches 
to chronic kidney disease’ by Shinichi Uchida; (3) ‘Physi-
ological architecture of the ion transport system in the 
epithelial tissue of the inner ear’ by Hiroshi Hibino, Fumi-
aki Nin, and Yoshihisa Kurachi; (4) ‘Robustness and vul-
nerability in cardiac electrophysiological systems: from 
a viewpoint of dynamical system theory’ by Kunichika 
Tsumoto, Yasutaka Kurata, Kazuharu Furutani, and Yoshi-
hisa Kurachi; and (5) ‘Multilevel systems medicine and 
software platform’ by Yoshiyuki Asai, Takeshi Abe, and 
Hiroaki Kitano. Detailed synopses of these presentations 
are presented in the following sections of this review.
System‑based understanding of adverse 
reactions of molecularly targeted drugs 
(Yoshiaki Kariya, Masashi Honma, 
and Hiroshi Suzuki)
Here we present an approach used to understand adverse 
reactions associated with molecularly targeted drugs. 
During the last two decades, several molecularly targeted 
drugs for cancer treatment have been developed, primar-
ily based on recent advances in cancer cell biology. One 
such example is the identification of mutations in the epi-
dermal growth factor receptor (EGFR) gene in lung cancer 
cells [7]. It has been reported that such EGFR mutations 
enhance cell growth and that inhibiting the mutated EGFR 
gene suppresses this enhanced cell growth. This has led to 
the development and clinical use of several EGFR inhibitors, 
such as gefitinib, erlotinib, afatinib, and osimertinib. In addi-
tion to EGFR inhibitors, tyrosine kinase inhibitors (TKIs), 
a class of molecules used very extensively in the clinical 
setting, are designed to inhibit the activity of target kinases 
by blocking their ATP binding pocket in the kinase domain. 
As the pocket structure is similar among various kinases, the 
kinase inhibitors often inhibit the activity of kinases that are 
unintended targets—i.e., “off-target” kinase. The off-target 
kinases are reported to be associated with adverse drug reac-
tions (ADRs), which are rarely observed with chemotherapy 
using cytotoxic anti-tumor drugs; therefore, the prediction 
and prevention of these ADRs are clinically important. How-
ever, although the mechanisms underlying the anti-tumor 
effect of molecularly targeted drugs have been clarified, the 
mechanism of ADRs is obscure as it is difficult to identify 
the kinases, including the off-target kinases, associated with 
the ADRs. In other words, numerous kinases can be a media-
tor of ADRs in terms of drug–kinase binding, which makes 
it difficult to clarify the mechanism analysis of ADRs. Sys-
tems biology can facilitate an understanding of these physi-
ological responses as an integrative outcome of numerous 
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complicated components. In this regard, an approach based 
on systems biology may be compatible with the mechanism 
analysis of ADRs and, therefore, we analyzed two kinase 
inhibitors.
The first analysis is about severe skin rash associated 
with erlotinib [8]. The occurrence rate of skin rash due to 
erlotinib, an EGFR inhibitor used clinically to treat various 
cancers, is extremely high (50%) compared with that due to 
gefitinib, another EGFR inhibitor (10%). Skin rash has on 
occasion forced treatment discontinuation, and it is a clinical 
problem to be overcome. To elucidate the mechanism, we 
narrowed down the candidate kinases using the comprehen-
sive data of affinities between kinase inhibitors and kinases 
reported previously [9]. We observed that the dissociation 
constant (Kd) value of EGFR is tenfold lower than that of 
most kinases, suggesting that erlotinib is a selective EGFR 
inhibitor. However, to elucidate the pharmacological phe-
nomenon, it is not sufficient to know the biochemical proper-
ties as drug concentration should also be considered in order 
to identify those kinases affected by clinical conditions. 
Therefore, we compared the kinase occupancies by erlotinib 
with those by gefitinib at their clinical concentrations. Two 
kinases—STK-10 and SLK—were found to be erlotinib-spe-
cific targets. As these two kinases have been reported to be 
functional in immune responses, especially in the suppres-
sion of interleukin-2 (IL-2) secretion in T cells, the effect of 
STK-10 and SLK knockdown in the presence or absence of 
drugs was tested. In the control knockdown condition, sup-
plementation of erlotinib at clinical concentration enhanced 
IL-2 secretion in Jurkat cells, whereas supplementation of 
gefitinib did not. Additionally, the knockdown of SKT-10 
enhanced IL-2 secretion, whereas the knockdown of SLK 
did not. Furthermore, there was no additive enhancement of 
IL-2 secretion by STK-10 knockdown together with erlotinib 
supplementation. These observations suggest that SKT-10 
is a mediator of enhanced IL-2 secretion with erlotinib sup-
plementation. IL-2 is a proinflammatory cytokine and its 
enhanced secretion may be a putative mechanism for severe 
skin rash. To confirm this hypothesis in vivo, we performed 
an irritant hypersensitivity assay using ddY mice, measuring 
earflap swelling after topical application of croton oil as an 
indicator of irritant hypersensitivity. When erlotinib or gefi-
tinib was administered to the mice at the dosage presenting 
an area under the curve and peak concentrations compara-
ble to human clinical cases, aggravation of skin inflamma-
tion was observed only in the erlotinib-administered group. 
Additionally, following the administration of an anti-IL-2 
neutralizing antibody, the enhanced inflammation by erlo-
tinib was significantly reduced. These in vivo observations 
suggest that severe skin rash observed in clinical situations 
is driven by enhanced IL-2 secretion via STK-10 “off-target” 
inhibition. Therefore, if we assume that the anti-tumor effect 
of erlotinib is mostly mediated by EGFR inhibition, it is 
theoretically possible to reduce the risk of skin rash with a 
negligible loss in therapeutic effect by optimizing the dose to 
inhibit EGFR but not STK-10. Collectively, the integration 
of comprehensive kinase affinity data and pharmacokinetic 
property is a powerful approach to elucidate the mechanism 
of TKI-associated ADRs.
The second analysis is about sunitinib-related ADRs [10]. 
Sunitinib is a multiple kinase inhibitor that is used clinically 
to treat various cancers. It has been reported that treatment 
with sunitinib causes ADRs, including platelet depletion, 
hypothyroidism, and cardiac and hepatic toxicities. Moreo-
ver, the occurrence rate of these ADRs is higher in patients 
treated with sunitinib than in patients treated with sorafenib, 
another multiple kinase inhibitor. As the occurrence of 
ADRs is one of major reasons for dose reduction, prevent-
ing/overcoming these ADRs is a clinically important objec-
tive, we performed a mechanism analysis of sunitinib-related 
ADRs. Similar to the mechanism analysis of erlotinib, we 
compared the kinases occupied by sunitinib and sorafenib. 
Phosphorylase kinase gamma subunit 1/2 (PHKG1/2), an 
enzyme that catabolizes glycogen decomposition to glucose-
1-phosphate, was found to be inhibited selectively by suni-
tinib at its clinical drug concentration. However, we were 
unable to identify the mechanism of ADRs only by this 
enzymatic property. Therefore, we attempted to integrate the 
molecular network surrounding this enzymatic reaction and 
subsequently found that the PHKG-related reactions were 
linked to the glycolysis/gluconeogenesis, pentose phosphate, 
and glutathione redox pathways (Fig. 1a). To narrow down 
the possible mechanism of ADRs, we also attempted to sim-
ulate these pathways in the presence of sunitinib. However, 
there are no reported quantitative dynamic simulation mod-
els that encompass all of these pathways, although there are 
several models that include some of these pathways. As each 
model was optimized to the background in which the model 
was constructed, it is difficult to build one large model by 
simply combining several models. Instead, we employed a 
sequential simulation approach for several parts of the mod-
els and made the following semi-quantitative predictions 
(Fig. 1b): (1) sunitinib treatment lowers glucose-6-phosphate 
synthesis in the glycolysis pathway (Fig. 1c); (2) lowered 
glucose-6-phosphate synthesis decreases the NADPH/
NADP+ ratio (Fig. 1d); and (3) a lowered NADPH/NADP+ 
ratio decreases the cytosolic concentration of reduced form 
of glutathione (GSH) (Fig. 1e). As cytosolic GSH protects 
intracellular components from oxidative stress, the simula-
tion resulted in the hypothesis that sunitinib enhances oxida-
tive stress, thereby damaging various organs. To validate this 
hypothesis, we measured several metabolites and oxidative 
stress markers in various organs using C57BL6/J mice dosed 
with sunitinib or sorafenib mixed in feed (Fig. 1f, g). The 
sunitinib-administered mice exhibited an exacerbated organ 
function marker, a decreased GSH to oxidized glutathione 
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(GSSG) ratio, and an increased level of the oxidative stress 
marker TBARS in all tested organs (liver, heart, and thyroid) 
and platelets, whereas the sorafenib-administered mice did 
not exhibit such disruptions. Furthermore, the concomi-
tant administration of an anti-oxidant protected against 
exacerbation of organ function. These results indicate that 
the mechanism of sunitinib ADRs is due to excess oxida-
tive stress caused by perturbation of the metabolic path-
way via PHKG1/2 inhibition. We also confirmed that the 
concomitant administration of sunitinib and alpha-tocoph-
erol nicotinate, an antioxidant, did not affect the antitumor 
effect of single treatment of sunitinib in in vivo experiments 
using xenograft mice, further indicating that system-based 
simulation and prediction is an effective strategy for mecha-
nism analysis of TKI-related ADRs.
For future application of our approaches, we should con-
sider the limitations to be overcome. One of the key factors 
affecting the success of sunitinib-related ADR analysis is 
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Fig. 1  Effect of sunitinib on metabolic pathways were simulated by 
sequential simulation of previously reported models. a–e The simula-
tion result suggests that sunitinib treatment induces oxidative stress. 
Phosphorylase kinase (PHK) gamma-related pathways were inte-
grated and simulated using three divided models (a) (for expanded 
version, see Electronic Supplementary Material figure). The path-
ways highlighted by black-boxed regions in a are enlarged in b–e, 
which also display the simulated change in the amount of different 
molecules as a function of free sunitinib concentration. f, g The pre-
diction was confirmed in in vivo experiments using a mouse model. 
A decrease in the glutathione/oxidized glutathione (GSH/GSSG) 
ratio was observed in many organs of mice treated with sunitinib. In 
addition, elimination of oxidative stress by α-tocopherol nicotinate 
(α-T.N.) can prevent organ toxicities. ALT Alanine aminotransferase, 
GPx glutathione peroxidase, GR glutathione reductase. The results of 
liver toxicity analyses are shown as representative data
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the properties of the metabolic pathway models used. As 
metabolic pathway models are well constructed and based on 
detailed knowledge of actual metabolic network structures, 
there are few undescribed and unknown pathways largely 
affecting simulation results. Additionally, metabolite con-
centrations and related enzymatic activity are directly meas-
urable; therefore, kinetic parameters of each model com-
ponent can be determined in a relatively accurate manner. 
Thus, simulation based on the previously established mod-
els helps to predict metabolic events other than the events 
focused on in the original analysis. To predict ADRs, there 
are also situations in which we would like to simulate signal 
transduction-related events, such as cell death, in addition to 
metabolic events. However, signal transduction models are 
established in a relatively less reductionistic manner due to 
experimental restrictions; therefore, there are few models 
widely available to analyze cell types other than the origi-
nally cells focused upon in the original studies. In many 
cases, to establish the kinetic models describing the intracel-
lular singling pathways, it is necessary to fine-tune specific 
cell types to reproduce experimental observations. There-
fore, the parameter values used in a particular model can-
not be easily transferred to another model describing other 
cell types. The comprehensive parameter determination 
approach might be helpful to overcome this problem. In the 
analysis of physiology-based pharmacokinetic models, tri-
als to identify a large number of parameter combinations to 
reproduce the observed drug concentration curve have been 
carried out [11]. Based on analysis of obtained parameter 
combinations, it was possible to calculate the representative 
parameter values and their respective variability in compli-
cated models. If we can obtain these variabilities together 
with the parameter values in the signal transduction models 
using just such an approach, the transferability of parameter 
values between different cell types will be improved as the 
variabilities may include information on differences in cell 
types. This information will greatly advance and expand the 
availability of simulation models. To conclude, although 
many tasks remain regarding the availability of simulation 
models, we show here that system-based analyses, including 
both comprehensive data analysis and model simulations, 
are useful for analyzing and predicting pharmacological out-
puts, including ADRs.
Multi‑omics approaches to chronic kidney 
disease (Shinichi Uchida)
Chronic kidney disease (CKD) is a major global health prob-
lem, and in Japan it is estimated that about 13% of the adult 
population have CKD. The prevalence of end stage kidney 
disease (ESKD) is also rapidly increasing. Renal replace-
ment treatment in expensive. It was reported that about 
40,000 patients were newly introduced to renal replacement 
therapy in Japan in a 1-year period, resulting in more than 
300,000 patients being currently on dialysis in Japan. CKD 
is also a well-known risk factor for cardiovascular mortal-
ity and morbidity. Thus, early recognition and treatment of 
CKD are important to prevent progression to cardiovascular 
diseases and ESKD. However, drugs specific for the treat-
ment of CKD are still lacking because there is insufficient 
knowledge on the mechanism of how the CKD kidney con-
tinues to fail irrespective of the primary cause. To identify 
novel target molecules and mechanisms to develop drugs for 
CKD, our group conducted multi-omics approaches to CKD. 
The methods used in mouse CKD models were transcrip-
tomics using microarrays and whole transcriptome shot-
gun sequencing (RNA-Seq) by next-generation sequencing 
(NGS), epigenomics, and metabolomics, including lipidom-
ics. The CKD model we used was a mouse 5/6 nephrectomy 
model in C57BL/6 and 129/SvJ mice, as CKD-resistant and 
-prone strains, respectively. Previous quantitative trait locus 
(QTL) analyses and single nucleotide polymorphism (SNP) 
data in both strains were also considered with these omics 
data. We also conducted human genomics focusing on famil-
ial CKD patients whose etiology of CKD was unknown. For 
this purpose, we prepared a comprehensive diagnostic panel 
for kidney diseases that simultaneously provided us with 
all of the exon information of the approximately  200 genes 
related to kidney diseases through NGS. This approach 
resulted in the identification of several candidate genes 
which could be important in the progression of CKD in the 
mouse CKD models and in human genetics; validation stud-
ies are currently under way. The utility of and the problems 
encountered in omics studies and future directions in system 
biology are discussed in this section.
Omics analyses imply a comprehensive assessment 
of a set of molecules, and studies using omics data have 
been driven by technological advances that have made 
cost-efficient and high-throughput analyses of biologi-
cal molecules possible. In the branch of molecular biol-
ogy known today as genomics, expression arrays were 
first generated in the late 1990s, leading to analyses of 
QTLs and the genome-wide association studies (GWAS). 
Among the various “omics”, genomics has been particu-
larly successful because (1) a high-quality reference of the 
human genome has been established, (2) high-throughput 
genotyping is possible by NGS, and (3) large coordinated 
cohorts are available and cohort studies are being con-
ducted. However, additional approaches for elucidating the 
causes of human diseases are still needed since (1) only a 
fraction of Mendelian diseases have been identified, and 
(2) the same genetic variants, even in the same family, 
often cause different phenotypes, probably due to differ-
ences in environmental and genetic backgrounds. Each 
type of omics data other than genomics data just provides 
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a list of differences associated with diseases. Analysis of 
only one omics data type only shows correlations, mostly 
reflecting reactive processes rather than causative ones. 
Therefore, integration of different omics data types is 
often necessary to elucidate potential causative changes 
that lead to diseases. In this respect, the development of 
system biology technologies that make possible the inte-
gration of different omics data and the identification of 
true causative changes is urgently needed.
CKD is a common complex disease entity that develops 
over time and is influenced by both genetic and environmen-
tal factors. Therefore, to clarify a final common mechanism 
of CKD progression irrespective of primary kidney diseases, 
coordinated sets of several layers of omics data are neces-
sary, even at multiple time points during the progression of 
the disease, from multiple disease-relevant tissues. To fulfill 
this criterion, researchers have to consider both animal and 
human studies.
In human studies, genomics has been one of the most 
powerful tools for identifying causative genes for diseases. 
GWAS have been performed, and the results from more than 
one study have suggested that SNPs in the UMOD gene 
encoding uromodulin are associated with CKD progression 
[12, 13]. Uromodulin, also called Tamm–Horsfall glycopro-
tein, is abundantly produced in the thick ascending limb of 
Henle’s loop in the kidney and excreted in the urine. The 
physiological role of this protein has not been fully estab-
lished since knockout mice do not show any apparent phe-
notypes. In addition to the association of UMOD expression 
with CKD progression identified in GWAS, UMOD has also 
been identified as a gene responsible for Mendelian forms 
of kidney diseases, such as familial juvenile hyperuricemic 
nephropathy (FJHN) and medullary cystic kidney diseases 
(MCKD). We recently identified  UMOD mutations in three 
familial CKD pedigrees; their clinical phenotypes are not 
those of FJHN and MCKD, and they are believed to be CKD 
of unknown etiology. It is well known that CKD phenotypes, 
even those caused by the same mutation, vary significantly 
among patients. Based on these observations, we speculated 
that powerful genes such as UMOD causing the Mendelian 
form of kidney diseases might be involved in more com-
mon mechanisms of CKD progression as modifier genes. 
Increased or decreased expression of SNP(s) or partial loss-
of-function mutations may not induce clear phenotypes, 
but either may be present more commonly in chronically 
progressive diseases such as CKD as modifier genes. In 
this context, the identification of mutations of previously 
identified causative genes for common kidney diseases in 
CKD patients is essential. Therefore, we built a compre-
hensive diagnostic panel for kidney diseases which tells us 
simultaneously all of the exon information of the approxi-
mately  200 genes related to kidney diseases by NGS [14] 
(Fig. 2). Further analyses of CKD patients with unknown 
disease etiology using this panel would clarify new thera-
peutic targets of CKD other than UMOD.
We also applied multi-omics approaches in experiments 
using mouse CKD models. Animal studies have certain 
advantages over human studies, including better reproduc-
ibility, better assessment of accurate phenotypes, increased 
ease in obtaining biological samples, and higher constancy 
of environmental factors. C57BL/6 and 129/SvJ mice 
are CKD-resistant and CKD-prone strains, respectively. 
We attempted to determine the source of this difference 
between the two strains using transcriptome, proteome, and 
metabolome data combined with SNP data and results from 
previous QTL analyses on both strains. Among the omics 
performed, we felt that metabolomics might be a power-
ful tool for CKD studies since (1) the kidney is the major 
organ involved in the excretion of various metabolites and 
(2) the levels of various metabolites in the body are dra-
matically affected in CKD. There may be metabolites that 
are primarily responsible for CKD progression, either by 
affecting enzymatic activity, gene transcription, and/or pro-
tein translation and modification. Something important for 
CKD progression not identified by other omics data can be 
found in metabolomics.
In summary, the omics approach is indispensable when 
the aim is to identify something new in biological studies. 
Methods to integrate multi-omics data to find the true causa-
tive element are not standardized. Consequently, there needs 
to be a concerted effort to obtain more coordinated sets of 
omics data of a certain quality.
Physiological architecture of the ion 
transport system in the epithelial tissue 
of the inner ear (Hiroshi Hibino, Fumiaki Nin, 
and Yoshihisa Kurachi)
In this section we discuss an ion transport system that main-
tains and regulates the electrochemical milieu in the cochlea 
of the mammalian inner ear. This tiny organ harbors two dif-
ferent extracellular solutions, namely, perilymph and endo-
lymph. Perilymph has an ionic composition similar to that 
of blood plasma, while endolymph contains a high potas-
sium ion concentration  ([K+]) of 150 mM and has a highly 
positive endocochlear potential (EP) of + 80 mV relative to 
perilymph (Fig. 3a) [15, 16]. The apical membranes of sen-
sory hair cells, which express mechanoelectrical transduc-
tion (MET) channels, are exposed to endolymph, and their 
basolateral surfaces are bathed in perilymph. In response 
to acoustic stimuli,  K+ from endolymph enters into the hair 
cells through the MET channels [17]. This process depolar-
izes the hair cells and induces the release of a neurotransmit-
ter from these cells that triggers propagation of the signals 
to the brain. The highly positive EP increases the driving 
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force for the  K+ entry and therefore contributes to the high 
sensitivity of hair cells.
It seems probable that in the cochlea,  K+ unidirection-
ally flows from endolymph to perilymph through the hair 
cell layer and then returns to endolymph across the lateral 
cochlear wall, an epithelial-like tissue (Fig. 3a) [18, 19]. 
This  K+ cycling or  K+ circulation current may constantly 
occur even without acoustic stimulation because under such 
conditions a subpopulation of MET channels are opened 
[20, 21]. The  K+ circulation current is likely to be driven 
by  K+ transport machineries in the lateral wall. The lateral 
wall is thought to consist of two layers: an outer and inner 
layer, respectively [19, 22]. In each layer, the apical surface 
expresses  K+ channels whereas the basolateral surface bears 
two different  K+ uptake transporters,  Na+,  K+-ATPases and 
the  Na+,  K+,2Cl−-cotransporter (NKCC) (Fig. 3b) [23, 24]. 
It has been proposed that these  K+ transport proteins are 
involved in the unidirectional transport of  K+. Moreover, 
physiological experiments point to the key roles of the 
channels and transporters in formation of the EP. Notably, 
a few research groups have analyzed the extracellular space 
between the inner and outer layers of the lateral wall, called 
the intrastrial space (IS), with a  K+-selective microelec-
trode that can simultaneously measure  [K+] and potential. 
The authors of these studies reported that the IS has a low 
 [K+] of several millimoles per liter and a highly positive 
potential similar to the EP (Fig. 3b, c) [22, 25]. There is 
a large  [K+] gradient across the outer layer’s apical mem-
brane that is dominated by  K+ channels (Fig. 3c). Based on 
these results, it is hypothesized that the positive IS potential 
is composed primarily of a  K+ diffusion potential (namely, 
the  K+ equilibrium potential,  EK) and a major origin of the 
EP [22, 26, 27]. Recently, our in vivo measurements with 
 K+-selective microelectrodes not only proved this hypothesis 
but also identified an additional element critically involved 
in the generation of the EP [28]. Imposition of anoxia, which 
inhibits mainly  K+ uptake transporters on the inner layer’s 
basolateral surface, in animals augments  [K+] in the IS with 
a minimal change in  [K+] inside the outer layer, thus reduc-
ing the amplitude of the  K+ diffusion potential and thereby 
also the IS potential (Fig. 3c). Simultaneously, the perturba-
tion decreases the  [K+] inside the inner layer and negligibly 
affects the  [K+] in endolymph. This situation increases the 
 K+ diffusion potential on the inner layer’s apical surface, 
Fig. 2  Targeted genes covered in the next-generation sequencing 
(NGS) panel. A total of 237 genes known to be responsible for vari-
ous inherited kidney diseases are included. aHUS Atypical hemo-
lytic uremic syndrome, FSGS focal segmental glomerulosclerosis, 
NDI nephrogenic diabetes insipidus, PHA pseudohypoaldosteronism, 
SRNS steroid resistant nephrotic syndrome
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Fig. 3  Electrochemical proper-
ties of the mammalian cochlea. 
a Structure of the cochlea. 
Overall view of the human ear 
is illustrated in the upper left 
panel. The upper right panel 
shows a cross-section of the 
cochlea. In the lower panel, the 
tissue and cellular composi-
tions of the cochlea as well as 
the electrochemical profiles of 
endolymph and perilymph (PL) 
are shown. Note that potas-
sium ions  (K+) unidirection-
ally circulate between the two 
types of lymph (endolymph and 
perilymph) through the lateral 
cochlear wall (described as a 
 K+ circulation current). The 
boxed area in a is enlarged in 
b. b Structure and molecular 
architecture of the lateral wall. 
The scheme shows that this 
tissue is made up of outer and 
inner layers; between the two 
layers lies the intrastrial space 
(IS). Ion channels and transport-
ers, which are likely to play a 
crucial role in the maintenance 
of endolymphatic high potential 
and of the  K+ circulation cur-
rent, are also described. ClC 
ClC-K/barttin-type chloride ion 
 (Cl−) channel, Kir4.1, KCNQ1/
KCNE1  K+ channels, NKCC 
 Na+,  K+,  2Cl−-cotransporter, 
NSC nonselective cation chan-
nel. vOB, vOA, vIB, vIA Membrane 
potential on the basolateral 
(subscript B) and apical (sub-
script A) surfaces of the outer 
(subscript O) and inner layer 
(subscript I). c Potential and 
ion profiles of the lateral wall, 
perilymph, and endolymph. Red 
lines and numbers and blue bars 
indicate the potential relative to 
perilymph and  K+ concentration 
 [K+] , respectively. In each of 
the five panels (a–e), repre-
sentative in vivo measurements 
obtained under the different 
conditions described above the 
blue bars are shown. Ouabain 
and bumetanide are inhibitors of 
sodium ion  (Na+),  K+-ATPases 
and NKCC, respectively. The 
upward and downward arrows 
show the increase and decrease 
of  [K+], respectively. iv Intra-
venous injection. Images in a–c 
were reproduced and adapted 
from Nin et al. [24]
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which expresses abundant  K+ channels. Owing to the emer-
gence of this potential difference, the EP reaches a negative 
value. Accordingly, the EP depends primarily on two  K+ 
diffusion potentials in the lateral wall: the one on the outer 
layer’s apical surface and the other on the inner layer’s apical 
surface (Fig. 3c) [24, 28].
Despite these observations, the relevance of the  K+ cir-
culation current throughout the cochlea to the EP remains 
uncertain because this current and the underlying ionic 
currents via the channels and transporters are unmeasur-
able in vivo. To address these issues, we have employed 
an in silico approach [29]. In our electrochemical model, 
 K+ circulates across six membrane domains, i.e., the apical 
and basolateral surfaces of the two layers in the lateral wall 
and those in the hair cell layer (Fig. 4a). Each surface is 
profiled by Hodgkin–Huxley-type equations that represent 
the function of the channels and transporters. Note that the 
model includes  Cl− channels and nonselective cation chan-
nels experimentally identified on the inner layer’s basolateral 
surface [30, 31]. The electrical circuits on these six surfaces 
are connected in series to drive the  K+ circulation current 
throughout the cochlea. Owing to this arrangement, the cir-
culation current stems from the sum of the ionic currents 
via all of the ion transport proteins on each surface and can 
control membrane potentials and ionic concentrations in the 
extracellular and intracellular spaces of the cochlea. This 
Nin–Hibino–Kurachi (NHK) model replicates the majority 
of experimental data on the electrochemical properties of 
endolymph and of the lateral wall under different conditions 
[29].
The model can theoretically explain the mechanism 
underlying alterations in the lateral-wall  [K+] profile dur-
ing anoxia that may represent ischemic conditions in the 
cochlea (Fig. 4b) [24, 29]. Under normal conditions, the 
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Fig. 4  In silico reproduction of electrochemical dynamics in the 
cochlea. A An outline of the original Nin–Hibino–Kurachi (NHK) 
model [29]. This model is characterized by outer and inner lay-
ers in the lateral wall and the hair cell layer, respectively. The pro-
file of each of the six surfaces is represented by electrical circuits 
that contain ion channels and transporters. These circuits are con-
nected in series and drive the  K+ circulation current under nor-
mal conditions (see Fig.  3a). ClC ClC-K/barttin-type  Cl− channel, 
Cl−-T  Cl−-transporter, MET mechanoelectrical transduction, Na+-
T  Na+-transporter. Reproduced and adapted from Nin et  al. [24]. B 
Ionic dynamics in the lateral wall. Ba and Bb indicate major ionic 
flows underlying the maintenance of or change in the electrochemi-
cal properties of the cochlea under normal and anoxic conditions. 
See the main text for details. Reproduced and adapted from Nin et al. 
[24]. C The updated NHK model. In the recent model (right panel), 
a few ion transport molecules incorporated into the basolateral sur-
face of the outer layer were changed on the basis of the experimental 
observations, as described in the main text and in references [33, 35]. 
Left panel indicates the corresponding portion in the original model. 
Reproduced and adapted from Yoshida et al. [36]. D Comparison of 
the experimental and simulated results. Da A microelectrode sensi-
tive to the potential (red) and  [K+] (blue) was inserted from PL into 
endolymph (EL) in a live guinea pig. After the passage, while the 
electrode was held in the IS, control artificial perilymph or a solu-
tion containing ouabain (10 µM), a blocker of  Na+,  K+-ATPases, was 
perfused into the perilymphatic space. The  [K+] measurement high-
lighted by the dashed box is expanded in the inset. A wedge above 
the trace shows the period when the electrode was moved forward or 
backward. Db Illustration of a simulation of the experimental condi-
tions shown in a via the recently updated NHK model.  [K+] behavior 
indicated by the dashed box is enlarged in the inset. Reproduced and 
adapted from Yoshida et al. [35]
442 The Journal of Physiological Sciences (2019) 69:433–451
1 3
circulation current is set to be composed purely of  K+. When 
the model is configured for anoxic conditions, where  K+ 
uptake transporters on the inner layer’s basolateral surface 
are inhibited, a fraction of the circulation current across this 
surface switches from  K+ to other ions via  Cl− channels and 
nonselective cation channels. As a consequence,  K+ inflow 
exceeds  K+ outflow in the IS and vice versa in the inner 
layer, causing  [K+] in the IS to increase and  [K+] inside the 
inner layer to decrease, as observed in the experiments (see 
Fig. 3c). These changes in the  [K+] profile result in a reduc-
tion of the IS potential and EP. Accordingly, the circulation 
current is likely to be coupled to the EP.
The ion transport machineries on the basolateral and api-
cal surfaces of the inner layer and on the apical surface of 
the outer layer have been actively characterized by in vivo 
and in silico assays, as described above. Nevertheless, the 
basolateral surface of the outer layer has not yet been suf-
ficiently analyzed. This surface expresses the proteins  Na+, 
 K+-ATPases and NKCC and manifests a resting membrane 
potential (RMP) of + 5 to + 12 mV in vivo (Fig. 3c) [28, 32, 
33]. In particular, because of this unusually positive value 
of RMP, the  K+ diffusion potential across the apical sur-
face of the outer layer can contribute to the formation of the 
highly positive values of the IS potential and EP (Fig. 3c). 
The  K+ uptake transporters and unique RMP were recently 
assessed in our electrophysiological experiments in live 
animals. First, perfusion into the perilymph—to which the 
outer layer’s basolateral surface is exposed—of a blocker for 
 Na+,  K+-ATPases reduces the  [K+] inside the outer layer, 
whereas perfusion of an inhibitor of NKCC affects this  [K+] 
property only negligibly (Fig. 3c) [32, 34]. Therefore,  Na+, 
 K+-ATPases—but not NKCC—convey  K+ in vivo. The sec-
ond observation was obtained with perilymphatic infusion 
of solutions that have a different ionic composition (Fig. 3c); 
the results indicate that the outer layer’s basolateral surface 
is more permeable to  Na+ than to  K+ and  Cl− under physi-
ological conditions, and this unusual property critically con-
tributes to the positive RMP [35].
On the basis of these findings, the NHK model has been 
updated (Fig. 4c) [36]. In this model, the basolateral surface 
of the outer layer harbors only  Na+,  K+-ATPases,  Na+ con-
ductance, and leak conductance, and lacks NKCC. These 
three machineries are assumed to be functionally coupled 
together to locally recycle  Na+; on the basolateral surface, 
this arrangement allows  Na+,  K+-ATPases to unidirection-
ally mediate  K+ transport (which constitutes the circulation 
current) and to maintain the positive RMP. With appropri-
ate parameter settings, the model approximately reproduces 
experimental measurements in various extracellular and 
intracellular spaces of the lateral wall and in endolymph 
under normal conditions. Moreover, pharmacological inhi-
bition of the outer-layer  Na+,  K+-ATPases is a condition that 
is inaccessible to the original NHK model but which can be 
simulated with the updated model. In vivo, perilymphatic 
perfusion of such an inhibitor reduces  [K+] inside the outer 
layer as well as  [K+] in the IS (Fig. 3c). Because the for-
mer changes more strongly than the latter, the  [K+] gradient 
across the apical surface of the outer layer is diminished, 
decreasing the IS potential and the EP. All of these meas-
urements are reasonably reproduced in the updated model. 
These observations reinforce the validity of the assumption 
in the model. It should be emphasized that although the outer 
layer’s basolateral surface expressing  Na+,  K+-ATPases does 
not face the IS, its  [K+], which is controlled by the circula-
tion current flowing throughout the cochlea, significantly 
changes (Fig. 3d). This result implies that  Na+,  K+-ATPases, 
 Na+ conductance, and leak conductance, which are coupled 
on the outer layer’s basolateral surface, are indeed linked to 
the circulation current as assumed in the model.
As described above, computer simulations and various 
types of experiments conducted by our laboratory and/or 
other groups have unveiled most of the physiological archi-
tecture necessary for the formation of the EP and circulation 
current. Nevertheless, several critical components remain to 
be determined. One example is a functional protein responsi-
ble for high  Na+ permeability on the outer layer’s basolateral 
surface that exhibits the unique RMP. Electrophysiological 
and pharmacological assays rule out the involvement of 
voltage-gated  Na+ channels or constitutively active epithe-
lial-type  Na+ channels [37, 38]. A three-dimensional model 
that describes the circulation current and electrochemical 
profile in the whole cochlea should be constructed with the 
aim to gain an understanding of the workings of this organ. 
In vivo, in vitro, and in silico studies will then be necessary 
to address the mysteries of hearing.
Robustness and vulnerability in cardiac 
electrophysiological systems: from the point 
of view of dynamical system theory 
(Kunichika Tsumoto, Yasutaka Kurata, 
Kazuharu Furutani, and Yoshihisa Kurachi)
The heart is a large, hierarchical, complex dynamic system, 
consisting of cellular, tissue, and organ systems [39]. The 
accurate and synchronous excitation propagation of action 
potentials (APs) in cardiomyocytes enables the heart to con-
tract and to function as a blood pump. The persistence of 
heart contraction during an organism’s lifetime represents 
the robustness of the system. To the contrary, the heart can 
also be regarded as a robust system with potential vulner-
abilities. Heart diseases resulting from arrhythmias, myo-
cardial infarction, heart failure, among others are typical 
examples of vulnerabilities in the heart. Such functional 
failures occur both dynamically and rapidly. In particu-
lar, arrhythmias, such as ventricular tachycardia (VT) and 
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ventricular fibrillation (VF), are the major causes of sudden 
death. The notion to view arrhythmias as dynamical diseases 
was proposed by physicists in the 1990s [40, 41]. Currently, 
an understanding of the dynamical aspects of arrhythmias 
is considered to be of crucial importance in the context of 
understanding the developmental mechanisms of vulnerabil-
ity in the heart and how to suppress them. In this section 
we describe recent advances in our understanding of the 
dynamical mechanism of early afterdepolarizations (EADs) 
that are caused in ventricular myocytes, based on in silico 
studies, and discuss the potential to gain new insights into 
the prevention and control of EAD-related arrhythmias.
Afterdepolarizations [42], such as EAD and delayed 
afterdepolarization, which are defined as transient depo-
larizations during AP phases 2–3 and 4, respectively, are 
believed to trigger lethal arrhythmias. In particular, EAD is 
well known to be a repolarization abnormality in the AP and 
to cause torsade de pointes (TdP) in patients with congenital 
long QT syndromes (LQTs) [43, 44] and heart failure [45]. 
In cardiomyocytes, the slow (IKs) and rapid components (IKr) 
of the delayed-rectifier  K+ channel currents play a critical 
role in the repolarization of APs. Decreases in these repo-
larization currents prolong the AP duration (APD). Numer-
ous experimental [46, 47] and theoretical studies [48, 49] 
have shown that excessive APD prolongation results in 
EADs. These observations imply that the incidence of 
TdP increases not only in patients with LQTS type 1 (IKs 
decrease) and type 2 (IKr decrease) and with heart failure, but 
also in patients treated with drugs that markedly represses 
repolarization currents [50, 51].
Many experimental studies have suggested that the reac-
tivation of the L-type  Ca2+ channel current (ICaL) during AP 
phases 2–3 in ventricular myocytes is a key mechanism of 
EAD formation [52, 53]. In silico studies using a mathemati-
cal model of guinea pig ventricular myocytes showed that 
EAD development during AP phases 2–3 is accompanied 
by ICaL reactivation [54, 55]. Also, in our recent theoreti-
cal studies [56, 57] using two human ventricular myocyte 
models developed by Kurata et al. [58] and O’Hara et al. 
[59], referred to as Kurata and ORd models, respectively, 
we determined that the occurrence of transient depolariza-
tions during AP plateau resulted from ICaL reactivation. An 
initiation mechanism of the EAD is as follows: under the 
condition of sufficiently reduced repolarization currents, 
APDs are markedly prolonged, and the AP repolarization 
is delayed. The repolarization delay leads to enhancement 
of the ICaL that is transiently increased by ICaL reactivation 
just before the termination of AP repolarization. Increasing 
reactivation of ICaL enhances an inward current component 
of the net ionic currents (Inet) and causes the inward imbal-
ance of current components in Inet, resulting in a first EAD 
during AP phases 2–3. Both the ORd and Kurata models 
[56, 57] as well as the guinea pig model [54] and another 
human ventricular myocyte model [49] were found to have 
this initiation mechanism in common.
The excitation phenomenon of cardiomyocytes is 
dynamical and nonlinear. The qualitative properties of 
dynamical behaviors observed in systems with nonlineari-
ties may change when a parameter of the system changes 
even slightly. In fields of nonlinear dynamics, such prop-
erty changes are called bifurcation [60, 61]. Examples of 
phenomena that arise via bifurcation include a transition 
from an equilibrium state to an oscillatory one or from a 
regular oscillation to a chaotic state. For example, working 
myocytes within the heart after an acute myocardial infarc-
tion suddenly acquire an automaticity through an accu-
mulation of extracellular  K+ ion, decrease in  K+ channel 
conductances, among others. This is a typical example of 
bifurcation. While it has been possible to gain an under-
standing of the EAD initiation mechanism using detailed 
computer simulation, how the transition between an AP 
without EAD and that with EAD dynamically occurs has 
remained unclear. Thus, we attempted to elucidate the tran-
sition mechanism by investigating changes in the stability 
of AP responses observed in the Kurata model without and 
with periodic stimuli [56, 57]. This is known as the bifurca-
tion analysis, which is a mathematical technique that can 
be used to evaluate changes in the stability of dynamical 
behaviors in dynamical systems, as well as the parameter 
dependency of these phenomena [61, 62]. An AP response 
without EADs showed prolongation of the APD when the IKr 
was reduced (blue AP traces in Fig. 5a). Further reduction of 
these repolarizing currents annihilated the prolonged stable 
AP response together with an unstable AP response (see 
overlapped blue and red AP traces in Fig. 5a). The reason 
for these responses was because the occurrence of a bifurca-
tion resulted in the stable and unstable responses coalesc-
ing and disappearing. Such a bifurcation is referred to as 
a saddle-node bifurcation. Because of this annihilation of 
AP without EADs, the system dynamics led to a transition 
to the potentially existing branch of AP with an EAD (gray 
arrow in Fig. 5a) as a new stable steady state; therefore, the 
emergence of EADs appeared as a sudden occurrence during 
reduction of the repolarizing current. Although it has been 
believed that excessive APD prolongation results in EAD 
via destabilization of the membrane potential, the emer-
gence of EADs in our ventricular myocyte model was not 
directly linked to destabilization of the membrane potential 
via APD prolongation. As a secondary effect of our bifur-
cation analyses, we found that the ORd and Kurata models 
exhibited multi-stable AP responses (see example in Fig. 5b) 
[56, 57]. Such responses are also known as multistability, for 
example, a bistability (birhythmicity) in which both of two 
distinct steady states (rhythmic responses) appear with the 
same parameter set, depending on an initial condition [63]. 
In rabbit ventricular myocytes and the in silico model, Xie 
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et al. [64] also observed intermittent spontaneous switch-
ing between AP responses with EADs and those without 
EADs that is similar to the bi-stable AP behavior seen with 
hysteresis; these authors demonstrated that variation in the 
intracellular  Na+ concentration  ([Na+]i) played important 
roles in the occurrence of bi-stable dynamics. The results of 
our in silico study also suggested that the multi-stable AP 
dynamics resulted from the variability in  [Na+]i, mediated 
via  Na+–K+ pump and  Na+/Ca2+ exchanger dynamics [57].
Such multi-stable AP behaviors may have significant 
implications for EAD-related arrhythmias. Conventionally, 
a mid-myocardial cell is known to be much more vulnerable 
to EAD formation than endocardial and epicardial myocytes 
[50, 65, 66]. Once EADs emerge within the mid-myocardial 
layer, the marked prolongation of APDs in the mid-myocar-
dial layer globally enhance APD heterogeneities (i.e., trans-
mural dispersion of repolarization) in the ventricular wall 
(Fig. 6a). This augmentation of APD heterogeneity causes 
electrotonic interactions (blue arrows in Fig. 2a), i.e., inter-
cellular currents via gap junctions between myocytes, in the 
boundary zones of the endocardial and mid-myocardial lay-
ers and of the mid-myocardial and epicardial layers, leading 
to re-entrant excitations following ectopic beats. Thus, an 
arrhythmogenic substrate is dynamically created in the ven-
tricle. In addition, the existence of multi-stable EAD dynam-
ics enables mid-myocardial cells to locally increase the APD 
heterogeneity (Fig. 6b). This also might be responsible for 
the generation of re-entrant arrhythmias. State variables, 
such as ion channel gating states, intracellular ion concentra-
tions, among others are not identical in each mid-myocardial 
cell. Such state variabilities contribute to the formation of 
local regions that exhibit each AP response within the mid-
myocardial layer (Fig. 6b), causing re-entrant excitations 
following the regional enhancement of APD heterogeneity 
(blue arrows in Fig. 6b).
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Fig. 5  Bifurcation phenomena and tetra-stable action potential (AP) 
dynamics observed in a human ventricular myocyte model. a A one-
parameter bifurcation diagram of the sampled membrane potential 
(Vm) in each AP response as a function of the maximum conduct-
ance (%GKr) of rapid components (IKr) of the delayed-rectifier  K+ 
channel currents in the Kurata model with 100%GKs. The maximum 
conductances of the slow component (IKs) and IKr of the delayed-
rectifier  K+ channel currents are expressed as a percentage of the 
control values. The solid and dashed lines represent stable and unsta-
ble AP responses, respectively. EAD Early afterdepolarization, SN 
saddle-node bifurcation. b An example of multi-stable AP dynam-
ics. Simulated tetra-stable AP trains and changes in intracellular  Na+ 
concentration  ([Na+]i) observed in the Kurata model at 39%GKr with 
70%GKs. The arrows (values in mM) indicate each  [Na+]i perturba-
tion at appropriate times during the simulated AP trains. Colored and 
gray lines indicate the steady-state and transient responses, respec-
tively. Dots indicate the application of current pulses. Pacing cycle 
length = 2 s. Each panel was modified based on Tsumoto et al. [57]
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As demonstrated by previous studies [67–69], the relation-
ship between EAD development in single-cell models and 
arrhythmogenicity in multi-cellular (tissue) models becomes 
more complicated due to the existence of gap–junction cou-
pling, i.e., electrotonic interaction. In well-coupled mid-myo-
cardial cells in the intact heart, the local APD heterogeneity 
may decrease because of an averaging effect resulting from the 
electrotonic effect [69, 70]. However, diminished gap–junction 
coupling, such as by ageing-related fibrosis, facilitates EAD 
formation [68, 71], creating suitable conditions for re-entry 
[48] and leading to the generation of lethal arrhythmias [72, 
73].
In addition to progress in experimental techniques, 
computer simulations will be indispensable techniques to 
understand complex dynamical behaviors, such as cardiac 
arrhythmias, and to elucidate their mechanisms. Thus, dynami-
cal system theory may enable us to provide new insights into 
biological system dynamics.
Multilevel systems medicine and software 
platform (Yoshiyuki Asai, Takeshi Abe, 
and Hiroaki Kitano)
Until the beginning of the present century, in medicine, 
difficult problems in physiology and life sciences, i.e., 
complex phenomena, such as pathology, were approached 
using an elemental reductionism method, which split prob-
lems into smaller elements, such as cells, proteins (mole-
cules), etc. As a result, an enormous amount of knowledge 
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layer) by exhibiting multi-stable 
APs, and an association to 
arrhythmogenic substrate for-
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was accumulated on each level of a biological system, 
namely, proteins, cells, organs, and tissues. Systems biol-
ogy can be described as a paradigm shift toward integral 
life sciences, through a synthesis of all of this accumulated 
knowledge into an understanding of life as a multi-level 
system. Systems biology has also driven the field of ‘omics 
research,’ which developed at the same time and involves 
consideration of the entirety of physiology under the moni-
ker “the physiome” [74, 75].
In response to conventional biology, which until now 
has focused on DNA, proteins, and other substances (“tan-
gibles”) that form biological functions, systems biology 
research focuses mainly on the dynamics (“intangibles”) 
of the networks that comprise the tangibles. Therefore, this 
paradigm shift can also be described as a paradigm shift 
from the science of “tangibles” to the science of “intangi-
bles”. When biological functions are re-appraised from this 
perspective, states of illness can be interpreted as disruptions 
in organismal dynamics that can have deleterious effects on 
an organism’s survival [76]. Even if individual elements are 
functioning properly, if the system parameter values, such as 
reaction coefficients, shift for any reason, the result is a dis-
ruption in system dynamics, possibly resulting in a state we 
recognize as illness. Mackey et al. dubbed this as “Dynami-
cal Disease” [77].
Applying this viewpoint to medical research can allow 
new therapeutic approaches to be considered [78]. To date, 
the general approach to illness has involved identification of 
the factor causing the disease and restoration of the diseased 
part to its original state. However, under a dynamics-based 
approach, it is possible that an adjustment of elements other 
than the element causing the disease could return disrupted 
dynamics to their original state, thereby enabling therapy. 
Kitano discusses this point of view from the perspective of 
the robustness and fragility of living systems, thereby devel-
oping the fundamental theory of systems biology [79, 80].
In many cases, a common approach in systems biology 
research is to conduct simulations using sensitive mathemat-
ical models created on the basis of previously accumulated 
data. Developments in molecular biology and bioinformat-
ics have helped explain the molecular basis of physiologi-
cal functions and have produced mathematical models at 
the molecular level, which is one factor driving the recent 
expansion in systems biology. The results of genome analy-
sis and epigenome analysis from next-generation sequenc-
ers have enabled progress, including pathway analysis and 
estimation of genetic regulation networks [81].
By conducting simulations, we can extract and observed 
specific dynamics of physiological systems. Empirical data 
can be regarded as one-sample path static data, even if they 
are time-series data recorded at specific time points. How-
ever, there have been research attempts to understand and 
intervene in biological functions, specifically changes in the 
status of systems over time, which are dynamic phenomena. 
Systems biology can be described as a technology that uses 
the processes discussed above to bridge the gap between 
static data and dynamic functions. Because mathematical 
models are built based on established knowledge of func-
tional networks, they can be thought of as mathematical 
expressions of collections of knowledge, or collections of 
hypotheses. The process of creating new knowledge through 
simulations can be considered to be a process of broadening 
and deepening existing knowledge.
In tandem with the accumulation of experimental data 
and developments in computing in the field of systems biol-
ogy, mathematical models of physiological functions have 
grown larger, more detailed, and more complex. As such, 
systematic support from software has become necessary 
for efficient model development. Efforts are being made to 
standardize the language in which models are described, 
with the Systems Biology Markup Language (SBML) [82], 
CellML language [83], and others having been proposed as 
candidates. Many tools to support these languages are also 
being developed. We have proposed a model descriptive 
language called Physiological Hierarchy Markup Language 
(PHML) [84] (http://physi odesi gner.org/phml/) and have 
released companion software, PhysioDesigner, which uses 
an intuitive graphical interface to support multi-level model 
creation, and a companion simulator, Flint [78]. In addition, 
a database of models described in PHML has been set up 
within Physiome.jp [79] (http://physi ome.jp). These tech-
nologies promote the sharing and re-use of models and data 
to enable accelerated model development. Snapshots of the 
software are shown in Fig. 7.
Figure 8 shows the time series results of a simulation 
run in Flint with a model of pancreatic beta cells developed 
on PhysioDesigner. This model includes each type of ion 
channel found on the cell membrane, along with the inter-
nal cellular processes discussed in the following text [80, 
85] (Fig. 8a). After the sugar concentration outside the cell 
increases, sugars are transported through the cell membrane 
and sent to the glycolytic pathway, and the pyruvate pro-
duced is fed into the citric acid cycle in the mitochondria. 
The product of the citric acid cycle, ATP, is released from 
the mitochondria, thereby deactivating the ATP-sensitive 
 K+ channels, which in turn promotes the influx of  Ca2+. An 
increase in  Ca2+ concentration in the cytoplasm triggers the 
exocytosis of insulin granules. Thus, this model shows multi-
ple levels, including molecular processes within the cell and 
processes in cell-membrane proteins. Notably, the overall 
model is written in PHML, but the internal mitochondria and 
glycolytic pathway processes are written in SBML. There-
fore, the model is a hybrid model in which SBML models 
have been imported into a PHML model. PhysioDesigner 
enables modeling that draws on the strengths of each mod-
eling language (Fig. 8b) [84].
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A B
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Fig. 7  Snapshots of the software PhysioDesigner and the database 
site. Upper left panel shows Physiome.jp where the model database is 
opened. Upper right snapshot shows the main window of PhysioDe-
signer. Lower right and left snapshots are of a simulator Flint, and 
three-dimension + time domain visualizer, PhysioVisualizer, respec-
tively. PHML Physiological Hierarchy Markup Language, SBML Sys-
tems Biology Markup Language
Fig. 8  Systems biology approach to pancreatic beta cells. a A model diagram of the multi-level insulin secretion system in pancreatic beta cells. 
b A model of pancreatic beta cells created with PhysioDesigner. c Simulation examples of calcium dynamics in a cell
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The far left panel of the simulation results (Fig. 8c) shows 
the dynamics of calcium concentration in the healthy state. 
Short-cycle oscillating fluctuations can be observed on the 
peaks of the long-cycle oscillations. Insulin release occurs 
when the calcium concentration is high. To model type II 
diabetes from this state, the one parameter value included 
in the model is changed to a small value. This parameter 
represents mitochondrial function; therefore, this change can 
be interpreted as a diabetic state resulting from decreased 
mitochondrial function, which causes the changes in intra-
cellular calcium concentration dynamics shown in the center 
panel. Because calcium concentration does not increase 
sufficiently, the amount of insulin released decreases. The 
third model, in which yet another parameter value changes, 
gives the calcium dynamics shown in the far right panel. 
The waveforms are slightly different compared with the 
healthy state, but the calcium concentration increased to 
nearly the same level. This means that the adjustment of 
the second parameter had a therapeutic effect. In fact, this 
second parameter represents the opening probability of the 
ATP-sensitive  K+ channels targeted by sulfonyl urea, which 
is one major drug used to treat type II diabetes. The value 
was decreased in order to close the channel. This simula-
tion shows one example of a search for therapies based on 
a dynamical understanding of disease, as discussed in the 
previous section.
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